AMT
32
4
KEY
33
3
CTAS
39
3
TROW
43
8
AA
18
-7
F
39
3
MMM
42
5
HAS
43
2
NRG
39
12
HUM
34
5
DG
29
12
CMG
51
-3
HIG
46
2
CAH
44
7
AON
28
-2
EQR
33
3
ZION
59
4
ECL
44
4
GILD
52
-2
AMP
43
3
AMT
32
4
KEY
33
3
CTAS
39
3
TROW
43
8
AA
18
-7
F
39
3
MMM
42
5
HAS
43
2
NRG
39
12
HUM
34
5
DG
29
12
CMG
51
-3
HIG
46
2
CAH
44
7
AON
28
-2
EQR
33
3
ZION
59
4
ECL
44
4
GILD
52
-2
AMP
43
3
Financhill
Back

Kiniksa Pharmaceuticals International PLC Stock Predictions

Stock Caught Trading Under Secret Name...

Find out more about the "hidden stock" here.
Sell
34

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
$20.32
Seasonality Move:
-3.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Today's Fastest Growing Company Might Surprise You

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Kiniksa Pharmaceuticals International PLC Stock Forecast

  • Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 3.8% based on the past 6 years of stock performance.
  • Kiniksa Pharmaceuticals International PLC has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Kiniksa Pharmaceuticals International PLC Stock Undervalued?
    The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $20.31. The Score for KNSA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • KNSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Kiniksa Pharmaceuticals International PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Kiniksa Pharmaceuticals International PLC has on average historically risen by 3.8% based on the past 6 years of stock performance.

Kiniksa Pharmaceuticals International PLC Stock Rating

Sell
34
Kiniksa Pharmaceuticals International PLC (KNSA) is a Sell

Is Kiniksa Pharmaceuticals International PLC overpriced?

  • Kiniksa Pharmaceuticals International PLC has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Kiniksa Pharmaceuticals International PLC Stock Price History

Is KNSA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Bermuda
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kiniksa.com

52-Week Data

52-Week High:
28.15
52-Week Low:
16.56

Prediction Charts

Market Cap:
1.5B
Price in USD:
20.31
Volume:
211.5K
Beta:
0.07

Technical Analysis

SMA50:
21.83
SMA100:
23.69
SMA200:
21.86
52-Wk Change:
1.65%

Stock Predictions

  • Is Kiniksa Pharmaceuticals International PLC stock public?
    Yes, Kiniksa Pharmaceuticals International PLC is a publicly traded company.
  • What is the Kiniksa Pharmaceuticals International PLC stock quote today?
    The Kiniksa Pharmaceuticals International PLC stock price is 20.31 USD today.
  • How to buy Kiniksa Pharmaceuticals International PLC stock online?
    You can buy Kiniksa Pharmaceuticals International PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 20.09 20.20 20.28 19.94
Dec-16 20.20 20.32 20.92 20.00
Dec-17 20.15 20.49 20.69 19.97
Dec-18 20.61 20.08 20.85 20.02
Dec-19 20.05 20.49 20.71 20.05
Dec-20 20.33 20.59 20.69 20.20
Dec-23 20.57 20.25 20.75 20.11
Dec-24 20.27 19.94 20.27 19.79
Dec-26 19.70 20.11 20.24 19.51
Dec-27 19.96 20.01 20.13 19.52
Dec-30 19.87 19.60 19.87 19.50
Dec-31 19.74 19.78 20.13 19.47
Jan-2 20.00 19.94 20.34 19.76
Jan-3 19.99 20.31 20.38 19.92

Kiniksa Pharmaceuticals International PLC Earnings

Kiniksa Pharmaceuticals International PLC Earnings Report: Per Share Kiniksa Pharmaceuticals International PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kiniksa Pharmaceuticals International PLC Forecast Revenue Growth

Kiniksa Pharmaceuticals International PLC Stock Analysis: Historical quarterly revenues per share for Kiniksa Pharmaceuticals International PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.53 per share.

* Kiniksa Pharmaceuticals International PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.